Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLYGet Free Report) have earned a consensus rating of “Moderate Buy” from the seven analysts that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and three have assigned a strong buy recommendation to the company.

RBGLY has been the topic of several recent research reports. Sanford C. Bernstein downgraded shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 4th. Citigroup upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a report on Tuesday, October 1st. UBS Group raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Wednesday, September 18th. Barclays raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Friday, October 4th. Finally, JPMorgan Chase & Co. cut shares of Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research note on Thursday, August 29th.

View Our Latest Report on Reckitt Benckiser Group

Reckitt Benckiser Group Stock Up 1.8 %

RBGLY opened at $12.26 on Tuesday. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97. Reckitt Benckiser Group has a 1-year low of $10.24 and a 1-year high of $15.03. The firm’s 50 day simple moving average is $12.32 and its two-hundred day simple moving average is $11.64.

Reckitt Benckiser Group Company Profile

(Get Free Report

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Featured Articles

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.